Oric Pharmaceuticals, Inc. ORIC Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s investing cash flow?
- Oric Pharmaceuticals, Inc. (ORIC) reported investing cash flow of -$17.98M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Oric Pharmaceuticals, Inc.'s investing cash flow decreased by 180.1% year-over-year, from $22.45M to -$17.98M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.